Skip to main content
SpringerLink
Log in

Factors Determining Spontaneous Ventricular Defibrillation

  • Letter to the Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wiggers CJ. The mechanism and nature of ventricular fibrillation. Am Heart J 1940; 20: 399-12.

    Google Scholar 

  2. Dorian P, Newman D. Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements. Cardiovasc Res 1997; 33: 485-94.

    PubMed  Google Scholar 

  3. Dorian P, Newman D. Effect of sotalol on ventricular fibrillation and defibrillation in human. Am J Cardiol 1993; 72: 72A-79A.

    PubMed  Google Scholar 

  4. Manoach M, Varon D, Neuman M, Netz H. Spontaneous termination and initiation of ventricular fibrillation as a function of heart size, age, autonomic autoregulation and drugs: A comparative study on different species of different age. Heart Vessels 1987; 56-68.

  5. Peters NS, J Coromilas, Severs NJ, Wit AL. Disturbed connexin 43 gap junction distribution correlates with location of circuits in the epicardial border zone of healing canine infarct that cause ventricular tachycardia. Circulation 1997; 95: 988-96.

    PubMed  Google Scholar 

  6. Manoach M, Watanabe Y. How can we facilitate spontaneous termination of ventricular fibrillation and prevent sudden cardiac death? J Cardiovasc Electrophysiol 1995; 6: 584-90.

    PubMed  Google Scholar 

  7. Miyachi EI, Manoach M, Uchiyama H, Watanabe Y. Is cyclic AMP involved in the defibrillating effect of sotalol? Life Sci 1995; 57: P L393-99.

    Google Scholar 

  8. Manoach M, Varon D, Shainberg A, et al. The protective effect of class III antiarrhythmic agents against calcium overload in cultured myocytes. Life Sci 1997; 61: P L 227-34.

    Google Scholar 

  9. Tribulova N, Ravingerova T, Okruhlicova L, Gabauer I, Fickova M, Manoach M. Modulation of cAMP level by tedisamil in guinea pig heart. Mol Cell Biochem 2000; 210: 75-80.

    PubMed  Google Scholar 

  10. Parmley WW, Rabinowitz B, Chuck L, Bonorris G, Katz JP. Comparative effects of sotalol and propranolol on papillary muscle and adenyl cyclase activity of myocardial extract of cats. J Clin Pharmacol 1972; 12: 127-35.

    Google Scholar 

  11. Manoach M, Varon D, Tribulova N, et al. The role of sarcoplasmic reticulum in the protective effect of class III drugs against Ca2+ overload. Gen Physiol Biophys 1999; 18(suppl 1): 19-25.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Heart Research, Slovak Academy of Sciences, Dubravska Cesta 9, 842 33, Bratislava, Slovak Republic

    Narcis Tribulova

  2. Department of Physiology, Tel Aviv University Medical School, Ramat-Aviv, Tel Aviv, 69978, Israel

    Mordechai Manoach

Authors
  1. Narcis Tribulova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mordechai Manoach
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tribulova, N., Manoach, M. Factors Determining Spontaneous Ventricular Defibrillation. Cardiovasc Drugs Ther 15, 189–190 (2001). https://doi.org/10.1023/A:1011187215901

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011187215901

Search

Navigation